FibroGen, Inc.
89Patents
73Active
89Granted
53Portfolio score
Filing activity: Dec 13, 1995 → Dec 23, 2020 · 27 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6992172B1 | Recombinant gelatins | Human Necessities | 93 | Expired |
| US7323475B2 | Nitrogen-containing heteroaryl compounds and methods of use thereof | Chemistry; Metallurgy | 56 | Expired |
| US7696223B2 | Pyrrolo- and Thiazolo-pyridine compounds, and methods of use thereof | Chemistry; Metallurgy | 42 | Active |
| US8017625B2 | Nitrogen-containing heteroaryl compounds and methods of use thereof | Chemistry; Metallurgy | 37 | Active |
| US8124582B2 | Treatment of diabetes | Human Necessities | 35 | Expired |
| US7928120B2 | Cyanoisoquinoline compounds and methods of use thereof | Chemistry; Metallurgy | 31 | Active |
| US7629357B2 | Nitrogen-containing heteroaryl compounds and methods of user thereof | Chemistry; Metallurgy | 29 | Active |
| US8324405B2 | Chromene derivatives and use thereof as HIF hydroxylase activity inhibitors | Chemistry; Metallurgy | 29 | Active |
| US7618940B2 | Fat regulation | Human Necessities | 28 | Expired |
| US8269008B2 | Oxazolopyridine and isoxazolopyridine derivatives for use in the treatment of HIF-mediated conditions | Human Necessities | 28 | Active |
| US8217043B2 | Compounds and methods for their use | Human Necessities | 26 | Active |
| US7863292B2 | Nitrogen-containing heteroaryl compounds and methods of use thereof | Chemistry; Metallurgy | 26 | Active |
| US8530404B2 | Compounds and methods for treatment of cancer | Human Necessities | 25 | Active |
| US7405274B2 | Connective tissue growth factor antibodies | Chemistry; Metallurgy | 23 | Expired |
| US8278325B2 | Nitrogen-containing heteroaryl compounds and methods of use thereof | Chemistry; Metallurgy | 22 | Active |
| US8759373B2 | Cyanoisoquinoline compounds and methods of use thereof | Chemistry; Metallurgy | 20 | Active |
| US8765956B2 | Nitrogen-containing heteroaryl compounds and methods of use thereof | Chemistry; Metallurgy | 18 | Active |
| US6358741B1 | Connective tissue growth factor (CTGF) and methods of use | Human Necessities | 16 | Expired |
| US8883823B2 | Crystalline forms of a prolyl hydroxylase inhibitor | Chemistry; Metallurgy | 15 | Active |
| US8318703B2 | Methods for improving kidney function | Physics | 15 | Active |
| US5925736A | Collagen-based methods and formulations for the treatment of arthritis | Emerging Cross-Sectional Technologies | 15 | Expired |
| US8952160B2 | Isothiazole-pyridine derivatives as modulators of HIF (hypoxia inducible factor) activity | Chemistry; Metallurgy | 15 | Active |
| US7115390B1 | Connective tissue growth factor fragments and methods and uses thereof | Human Necessities | 15 | Expired |
| US8703795B2 | Thienopyridine compounds, and methods of use thereof | Chemistry; Metallurgy | 14 | Active |
| US7713986B2 | Compounds and methods for treatment of chemotherapy-induced anemia | Human Necessities | 14 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.